Weekly Roundup: CF Industries Rises, Centene Sinks, Hims & Hers Skyrockets - podcast episode cover

Weekly Roundup: CF Industries Rises, Centene Sinks, Hims & Hers Skyrockets

Mar 14, 20263 min
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers, we take a look at some of the biggest gainers and decliners from the past week: 

- CF Industries (CF) saw its shares trade higher this week, along with other stocks in the chemical and fertilizer space. Fertilizer markets are tightening as the escalating conflict in the Middle East threatens global supplies of nitrogen-based crop nutrients, boosting companies such as CF Industries Holdings Inc., the world’s largest producer of ammonia. CF Industries shares rose as much as 14% on Thursday, the biggest intraday jump since 2020 and to a record high. The Illinois-based company controls nearly 40% of the North American nitrogen fertilizer market, while Nutrien (NTR) — which climbed 7.6% to the highest price in more than three years — controls another 22%.

- Centene (CNC) shares sank on Tuesday after the health insurer flagged rising medical costs and declining membership, adding to an already cautious outlook for the industry. Centene said it expects enrollment in the Affordable Care Act marketplace will decline by about 35% or more across the industry after some federal ACA subsidies expired. It sees its own membership potentially dropping even faster. The company’s membership dropped from 5.5 million in December to 3.6 million in February, a decline that CEO Sarah London said was “in line with our expectations.” 

- Hims & Hers (HIMS) shares posted their best week on record as a new partnership with Novo Nordisk A/S fuels fresh optimism about the company’s future in weight-loss drugs. The San Francisco-based company’s stock climbed about 57% this week, rallying in four of the past five trading sessions. Earlier this week, the telehealth company said it would work with Novo to sell blockbusters Ozempic and Wegovy on its platform, ending a feud between the firms. Novo also agreed to drop a lawsuit it filed against Hims last month. In return, Hims will no longer advertise compounded versions of Novo’s drugs, but it will still sell copies of Ozempic and Wegovy if a doctor says a patient needs them. 

See omnystudio.com/listener for privacy information.

Transcript

Speaker 1

Bloomberg Audio Studios, Podcasts, radio News.

Speaker 2

The Stock Movers report, your roundup of companies making moves in the stock market, harnessing the power of Bloomberg Data.

Speaker 3

I'm Krol Masser along with Tim Stenevick. Let's get to some stocks on the move this past week with us once again is Bloomberg News Equities reporter Avalon Pernaw. She's here in studio. Good to have you here. Crazy week, lots of moves. Where shall we begin?

Speaker 1

Absolutely, we can go ahead and start off with CF Industries. That's ticker cf IT closed up twelve percent to end the week at our record high. That's after chemical and fertilizer stocks. Pretty broadly, we're hired this week amid continued disruptions to the Strait of her moves. And the Middle East is a very large supplier of fertilizers just across

the world. And Bloomberg Intelligence is highlighting in a note earlier this week about the poor timing of this conflict given the Northern hemisphere is supposed to be beginnings spring planting. We'll see what happens.

Speaker 3

No, yeah, I mean yeah. And there's a bunch of key components to go into fertilizer that come out of the region Saudi Arabia specifically. I had no idea, but yeah, we definitely saw those names moving in a big way. Let's go to your next name. Senteen ticker CNC.

Speaker 1

Absolutely down twenty one percent this week for its biggest weekly drop since July. That's after the CEO made fairly cautious comments on utilization and also membership at an industry conference earlier this week. Sarah London mentioned that it's expecting its membership and its Affordable Care Act plans to be down nearly forty percent this year. For reference, they were

originally expecting like mid teens to the thirties. It's a big difference, big difference, and they've already been dealt a pretty harsh hand in terms of health insurance across the board, given Congress failed to renew Obamacare subsidies earlier this year. So we'll keep an eye out.

Speaker 3

Yeah, this stock has been getting beat up with some of the other some of its peers down this year by seven sixteen point three percent. Hymns and hers, let's go. Yeah, I feel like this name has been in the news a lot over the last week or so.

Speaker 1

It sure has ticker Hymns gaining fifty Why is it always you guys get first?

Speaker 2

Billy?

Speaker 3

Why are you looking at me?

Speaker 2

I don't know her? In the Bloomberg terminal takes you to her, She's which is hs y.

Speaker 3

Maybe you gotta work on this anyway, take it away. Her looks like hers was available story of our lives. I think this company used to just be called Hymns, okay, and then we're like, oh yeah, there's like more than fifty percent of the population. Is those other folks still get mad at me about.

Speaker 2

This Hymns and hers? What do you get?

Speaker 3

It?

Speaker 1

Had its the best week ever at Sufter announcing a pact with Novo Nordisks, they've kind of had a frenemies back to friends situation happened. They agreed to work together again to sell Novo's blockbuster obesity drugs, and Needam actually said in an interview with US that this deal alleviates some major near term concerns and also puts a company back on the right foot for long term growth.

Speaker 3

Well done putting up with us again, but she does it so well. Avalon Parnell, thank you so much. Bloomberg News Equities reporter with some of the big stack movers of the week.

Speaker 2

Overall, the Stockmovers Report from Bloomberg Radio. Check back with us throughout the day for the latest roundup of companies making news on Wall Street and for the latest market moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube, Bloomberg dot com, and on Applecarplay and Android Auto with the Bloomberg Business app.

Transcript source: Provided by creator in RSS feed: download file
For the best experience, listen in Metacast app for iOS or Android